Publications by authors named "F Frigeri"

Claim this Profile
E
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study.
Maria Carmen Martorelli, Novella Pugliese, Maria Di Perna, Danilo De Novellis, Assunta Lombardi, Ferdinando Frigeri

Eur J Haematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.
Danilo De Novellis, Salvatore Palmieri, Stefano Rocco, Daniele Derudas, Roberta Della Pepa, Ferdinando Frigeri

Ann Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
Danilo De Novellis, Daniele Derudas, Donatella Vincelli, Raffaele Fontana, Roberta Della Pepa, Ferdinando Frigeri

Eur J Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.
Sonia Morè, Irene Federici, Alessandra Bossi, Serena Rupoli, Erika Morsia, Ferdinando Frigeri

Hemasphere· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.
Francesca Romana Mauro, Potito Rosario Scalzulli, Lydia Scarfò, Carla Minoia, Roberta Murru, Ferdinando Frigeri

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis